v3.26.1
Note 20 - Non-controlling Interests - Summary of Income Statement Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
May 31, 2026
May 31, 2025
May 31, 2024
Net loss $ (105,158) $ (2,181,356) $ (222,404)
Net comprehensive (loss) income (104,951) (2,180,926) (219,283)
Comprehensive (loss) income attributable to NCI 17,616 5,376 22,587
Additional income attributable to NCI 0    
Subsidiaries [Member]      
Revenue   78,414 103,331
Total expenses   74,575 82,349
Net loss   3,839 20,982
Other comprehensive (loss) income   (49) (172)
Net comprehensive (loss) income   3,790 20,810
Comprehensive (loss) income attributable to NCI   5,376 17,251
Additional income attributable to NCI   0 5,336
Net comprehensive (loss) income attributable to NCI   5,376 22,587
Superhero Acquisition LP [Member]      
Revenue 29 0 0
Total expenses 39 20,000 42,681
Net loss (10) (20,000) (42,681)
Other comprehensive (loss) income 0 0 0
Net comprehensive (loss) income $ (10) $ (20,000) $ (42,681)
Non-controlling interest % 25.00% 32.00% 32.00%
Comprehensive (loss) income attributable to NCI $ (3) $ (6,400) $ (13,658)
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI (3) (6,400) (13,658)
CC Pharma Nordic ApS [Member]      
Revenue 81,477 0 0
Total expenses 48,459 11 (1,064)
Net loss 33,018 (11) 1,064
Other comprehensive (loss) income 2,899 8 (9)
Net comprehensive (loss) income $ 35,917 $ (3) $ 1,055
Non-controlling interest % 49.00% 25.00% 25.00%
Comprehensive (loss) income attributable to NCI $ 17,599 $ (1) $ 264
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI 17,599 (1) 264
Aphria Diamond [Member]      
Revenue 0 78,414 103,331
Total expenses (622) 54,274 40,935
Net loss 622 24,140 62,396
Other comprehensive (loss) income (425) (45) 171
Net comprehensive (loss) income $ 197 $ 24,095 $ 62,567
Non-controlling interest % 10.00% 49.00% 49.00%
Comprehensive (loss) income attributable to NCI $ 20 $ 11,807 $ 30,658
Additional income attributable to NCI   0 5,336
Net comprehensive (loss) income attributable to NCI 20 11,807 35,994
ColCanna S.A.S. [Member]      
Revenue 81,506 0 0
Total expenses 47,876 290 (203)
Net loss 33,630 (290) 203
Other comprehensive (loss) income 2,474 (12) (334)
Net comprehensive (loss) income 36,104 $ (302) $ (131)
Non-controlling interest %   10.00% 10.00%
Comprehensive (loss) income attributable to NCI 17,616 $ (30) $ (13)
Additional income attributable to NCI   0 0
Net comprehensive (loss) income attributable to NCI $ 17,616 $ (30) $ (13)